Loading...
HomeMy WebLinkAbout11.21.25 Board Correspondence - FW_ Moderna Knew in 2017 That Its mRNA Vaccine Lipid Nanoparticles Enter the Bloodstream and Accumulate in the Liver, ….ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening attachments, clicking on links, or replying.. From:Clerk of the Board To:Mutony, Heather Cc:Lee, Lewis Subject:Board Correspondence - FW: Moderna Knew in 2017 That Its mRNA Vaccine Lipid Nanoparticles Enter the Bloodstream and Accumulate in the Liver, … Date:Monday, November 24, 2025 2:49:51 PM Please see Board Correspondence - From: lance dreiss <lancedreiss@att.net> Sent: Friday, November 21, 2025 7:25 PM To: Shared Mailbox Clerk of the Board <pcbs@countyofplumas.com>; Soderstrom, Monica <msoderstrom@buttecounty.net>; Assemblymember.Gallagher@assembly.ca.gov; Senator.Dahle@senate.ca.gov; davidhollister@countyofplumas.com; sheriff@countyofplumas.com; District Attorney <District_Attorney@buttecounty.net>; Kimmelshue, Tod <TKimmelshue@buttecounty.net>; Pickett, Andy <APickett@buttecounty.net>; Connelly, Bill <BConnelly@buttecounty.net>; Teeter, Doug <DTeeter@buttecounty.net>; Julie Threet <julie4butte5@gmail.com>; Waugh, Melanie <mwaugh@buttecounty.net>; Kitts, Melissa <mkitts@buttecounty.net>; Durfee, Peter <PDurfee@buttecounty.net>; Ritter, Tami <TRitter@buttecounty.net>; Teri DuBose <Teri.DuBose@mail.house.gov>; Congressman Doug LaMalfa <CA01DL.Outreach@mail.house.gov>; Stephens, Brad J. <BStephens@buttecounty.net>; Clerk of the Board <clerkoftheboard@buttecounty.net> Subject: Fwd: Moderna Knew in 2017 That Its mRNA Vaccine Lipid Nanoparticles Enter the Bloodstream and Accumulate in the Liver, … Public Record “Moderna submitted data in November 2017 proving their mRNA vaccine lipid nanoparticles (LNPs) accumulate in mammalian liver, spleen, plasma (blood), kidneys, heart, and lungs— the same technology Moderna and Pfizer later used in billions of COVID-19 doses. No one who lined up for those shots was ever told—let alone asked to consent—that the lipid nanoparticles carrying the mRNA would traffic through their blood and into their vital organs. The LNPs were shown to reach major organs and enter the bloodstream within 1 hour.“ diana dreiss Begin forwarded message: From: Jon Fleetwood <jonfleetwood@substack.com Date: November 21, 2025 at 12:38:11 PM PST To: lancedreiss@att.net Subject: Moderna Knew in 2017 That Its mRNA Vaccine Lipid Nanoparticles Enter the Bloodstream and Accumulate in the Liver, … Reply-To: Jon Fleetwood <reply+2yv92k&kcryl&&46e0bf2e53f35b8e6450e18eec2677160f14f31bada6 f61b642a4e986b7ad5a9@mg1.substack.com>  Two whole years before the COVID-19 pandemic during which billions were injected with LNP-containing vaccines, raising informed consent concerns.͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­Forwarded this email? Subscribe here for moreModerna Knew in 2017 That Its mRNAVaccine Lipid Nanoparticles Enter theBloodstream and Accumulate in theLiver, Spleen, Kidneys, Heart, andLungs: 'Molecular Therapy' Journal Two whole years before the COVID-19 pandemic during which billions were injected with LNP-containing vaccines, raising informed consent concerns. JON FLEETWOOD NOV 21 READ IN APP Moderna submitted data in November 2017 proving their mRNA vaccine lipid nanoparticles (LNPs) accumulate in mammalian liver, spleen, plasma (blood), kidneys, heart, and lungs—the same technology Moderna and Pfizer later used in billions of COVID-19 doses. No one who lined up for those shots was ever told—let alone asked to consent—that the lipid nanoparticles carrying the mRNA would traffic through their blood and into their vital organs. The LNPs were shown to reach major organs and enter the bloodstream within 1 hour. The particles persisted in those tissues at least 24–48 hours (the Moderna study didn’t track LNP distribution past 2 days), with accumulation when repeatedly dosed. In November 2017, two years before the COVID-19 pandemic, Sabnis et al. submitted biodistribution data regarding Moderna’s mRNA-1325 Zika vaccine, received by Molecular Therapy journal. The authors were Moderna’s own scientists. Share Share Jon Fleetwood Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood. If you value this reporting, consider upgrading to a paid subscription. Main (1) 1.63MB ∙ PDF file Download The study confirms Moderna’s LNPs—called MC3 (DLin-MC3-DMA)—ended up in mammalian liver, spleen, blood, kidney, heart, and lung: “Following dosing with MC3 LNPs, lipid was detected in liver, spleen, plasma, concentrations. Accumulation of MC3 was observed after each dose. Liver and spleen had the highest levels of lipid 5, however, significantly lower levels than MC3. Lipid 5 was also detected in plasma, lung, and kidney, but not in heart.” A January 2023 Nature Reviews Drug Discovery paper co-authored by Moderna scientists bluntly admits that avoiding “unacceptable toxicity” in mRNA vaccines remains a major challenge, warning that “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs all present toxicity concerns” and that the way these vaccines spread through the body can cause harm due to “cell tropism and tissue distribution… and their possible reactogenicity.” Nevertheless, back in July of this year, the FDA approved the supplemental Biologics License Application (sBLA) for Spikevax®, Moderna’s LNP-containing COVID-19 vaccine, in children 6 months through 11 years of age. The current head of the FDA is Dr. Martin A. Makary, who was confirmed as Commissioner of Food and Drugs in March. And now, with their own 2017 biodistribution data in hand, there is no escaping the obvious: Moderna knew exactly where these nanoparticles were going in the body— and they rolled them out to the world anyway. With repeat blessings from the FDA. Upgrade to paid Share Share Jon Fleetwood Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood. If you value this reporting, consider upgrading to a paid subscription. For advertising & sponsorship opportunities reaching 300,000+ monthly viewers, contact us by clicking below. Message Jon Fleetwood DARPA’s Secret 60-Day Pandemic Pipeline:FOIA Documents Reveal U.S. MilitaryProgram to Synthesize Viruses From DigitalSequences and Mass-Produce mRNACountermeasures JON FLEETWOOD ·NOV 19 Read full story The Claim 'Vaccines Do Not Cause Autism'Is Not an Evidence-Based Claim, CDCConfirms JON FLEETWOOD ·NOV 20 Read full story Moderna's Parent Company Now SprayingRNA Into Your Food JON FLEETWOOD ·JUL 24 Read full story U.S. Gov't Taps Pfizer, Moderna for mRNABird Flu Jabs Despite Already-AvailableSafe, Effective Treatments JON FLEETWOOD ·MAY 30, 2024 Read full story Moderna Receives Full FDA Approval for'Toxic' Shot in Children at 'Increased Riskfor COVID-19 Disease' JON FLEETWOOD ·JUL 10 Read full story Moderna Jab mRNA Enters Blood, Stays forWeeks—We Were Told It Wouldn't: Journal'ACS Nano' JON FLEETWOOD ·DECEMBER 20, 2024 Read full story Infants Vaccinated with Moderna RSVmRNA Jab 3x More Likely to Develop RSVDisease Than Unvaccinated: FDA JON FLEETWOOD ·DECEMBER 12, 2024 Read full story DARPA Linked to COVID-19 Virus andModerna Jab Creation Since 2012, CoveredUp EcoHealth Gain-of-Function Research in2021 JON FLEETWOOD ·NOVEMBER 22, 2024 Read full story U.S. Cancels $700 Million Moderna Bird FluVaccine Contract JON FLEETWOOD ·MAY 29 Read full story Moderna Scientists Admit 'Risks of mRNADrug and Vaccine Toxicity': Journal'Nature' JON FLEETWOOD ·JANUARY 24, 2024 Read full story Moderna Loses $8.3 Billion in Two Years asCOVID Vaccine Demand Collapses,Scrambles to Push New mRNA Shots JON FLEETWOOD ·FEB 26 Read full story Moderna Patent Says Vitamin C May BlockSpike Protein Production in COVID-19 Jab JON FLEETWOOD ·NOVEMBER 15, 2024 Read full story You're currently a free subscriber to JonFleetwood.com. For the full experience, upgrade your subscription. Upgrade to paid LIKE COMMENT RESTACK © 2025 Jon Fleetwood548 Market Street PMB 72296, San Francisco, CA 94104 Unsubscribe